PT1597274E - Hsp60 de arthrobacter - Google Patents

Hsp60 de arthrobacter Download PDF

Info

Publication number
PT1597274E
PT1597274E PT04710796T PT04710796T PT1597274E PT 1597274 E PT1597274 E PT 1597274E PT 04710796 T PT04710796 T PT 04710796T PT 04710796 T PT04710796 T PT 04710796T PT 1597274 E PT1597274 E PT 1597274E
Authority
PT
Portugal
Prior art keywords
arthrobacter
hsp60
sequenced
fish
believed
Prior art date
Application number
PT04710796T
Other languages
English (en)
Inventor
Steven Gareth Griffiths
Rachel Jane Ritchie
Nathalie C Simard
Original Assignee
Novartis Ag
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9953082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1597274(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Novartis Pharma Gmbh filed Critical Novartis Ag
Publication of PT1597274E publication Critical patent/PT1597274E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT04710796T 2003-02-14 2004-02-13 Hsp60 de arthrobacter PT1597274E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0303507.8A GB0303507D0 (en) 2003-02-14 2003-02-14 Organic compounds

Publications (1)

Publication Number Publication Date
PT1597274E true PT1597274E (pt) 2009-08-24

Family

ID=9953082

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04710796T PT1597274E (pt) 2003-02-14 2004-02-13 Hsp60 de arthrobacter

Country Status (20)

Country Link
US (2) US7297783B2 (pt)
EP (1) EP1597274B1 (pt)
JP (1) JP5561892B2 (pt)
CN (1) CN1751064B (pt)
AT (1) ATE437177T1 (pt)
AU (1) AU2004212322B2 (pt)
CA (1) CA2513061C (pt)
CL (1) CL2004000262A1 (pt)
CY (1) CY1109349T1 (pt)
DE (1) DE602004022138D1 (pt)
DK (1) DK1597274T3 (pt)
ES (1) ES2328140T3 (pt)
GB (1) GB0303507D0 (pt)
HK (1) HK1085487A1 (pt)
IS (1) IS8018A (pt)
NO (1) NO20054239L (pt)
NZ (1) NZ541507A (pt)
PT (1) PT1597274E (pt)
SI (1) SI1597274T1 (pt)
WO (1) WO2004071387A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2330738T3 (es) * 2002-07-15 2009-12-15 Novartis Ag Vacuna contra septicemia rickettsial de salmonidos basada en arthrobacter.
CN105039221B (zh) * 2015-08-07 2019-04-16 中国农业科学院哈尔滨兽医研究所 一株冷水鱼益生菌节杆菌菌株及其用途
CN113493788B (zh) * 2021-05-24 2023-06-23 上海晶诺生物科技有限公司 一种分枝杆菌启动子库及其应用
WO2023078279A1 (zh) * 2021-11-04 2023-05-11 澄交生物科技股份有限公司 免疫原性组合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1548388A (en) * 1987-02-02 1988-08-24 Whitehead Institute For Biomedical Research Mycobacterium tuberculosis genes and encoding protein antigens
US5165925A (en) * 1989-05-02 1992-11-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine for immunizing fish against infectious pancreatic necrosis virus
FR2666588B1 (fr) * 1990-09-10 1994-02-11 Pasteur Institut Sequence nucleotidique regulatrice de l'initiation de transcription.
DK0700445T3 (da) 1993-06-04 2002-05-13 Whitehead Biomedical Inst Stressproteiner og anvendelser deraf
EP0888053A4 (en) * 1995-08-18 2002-07-31 Sloan Kettering Inst Cancer METHOD FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASES AND COMPOSITIONS USEFUL FOR THE TREATMENT
IL136821A0 (en) * 1997-12-23 2001-06-14 Genesis Res & Dev Corp Ltd Compositions derived from mycobacterium vaccae and methods for their use
EP1196772A2 (en) 1999-07-08 2002-04-17 Stressgen Biotechnologies Corporation Induction of a th1-like response in vitro
JP2003507074A (ja) * 1999-08-26 2003-02-25 ビーエーエスエフ プランド サイエンス ゲーエムベーハー 構成的植物ｖ−ａｔｐアーゼプロモーターにより制御される植物遺伝子発現
AU7033400A (en) 1999-08-30 2001-03-26 Jehad Mikhaiel Charo Induction of cytotoxic t lymphocyte response by hla class ia restricted epitopesof mycobacterial heat shock protein 65
KR20030074787A (ko) * 2001-02-05 2003-09-19 스트레스젠 바이오테크놀러지스 코포레이션 Ｂ형 간염 바이러스 치료
GB0216414D0 (en) * 2002-07-15 2002-08-21 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
SI1597274T1 (sl) 2009-12-31
CN1751064B (zh) 2010-05-26
AU2004212322A1 (en) 2004-08-26
IS8018A (is) 2005-09-12
WO2004071387A3 (en) 2005-03-24
WO2004071387A2 (en) 2004-08-26
CL2004000262A1 (es) 2005-03-28
NO20054239D0 (no) 2005-09-13
DE602004022138D1 (de) 2009-09-03
ES2328140T3 (es) 2009-11-10
DK1597274T3 (da) 2009-11-23
NO20054239L (no) 2005-11-03
US20080287664A1 (en) 2008-11-20
US7803924B2 (en) 2010-09-28
CN1751064A (zh) 2006-03-22
NZ541507A (en) 2008-03-28
HK1085487A1 (en) 2006-08-25
EP1597274A2 (en) 2005-11-23
CA2513061C (en) 2015-12-22
JP2006517406A (ja) 2006-07-27
US7297783B2 (en) 2007-11-20
EP1597274B1 (en) 2009-07-22
JP5561892B2 (ja) 2014-07-30
AU2004212322B2 (en) 2008-01-17
CA2513061A1 (en) 2004-08-26
GB0303507D0 (en) 2003-03-19
US20060127416A1 (en) 2006-06-15
ATE437177T1 (de) 2009-08-15
CY1109349T1 (el) 2014-07-02

Similar Documents

Publication Publication Date Title
HK1075901A1 (en) Hsp70 from arthrobacter
MXPA05013973A (es) Metodos para producir, mejorar y sustentar respuestas inmunes contra epitopes restringidos mhc clase i, para propositos profilacticos o terapeuticos.
HK1108713A1 (en) Animal protein free media for cultivation of cells
WO2007137300A3 (en) Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
WO2006095330A3 (en) Methods and immunogenic cell preparations for treating antigen-associated diseases
SG158154A1 (en) Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes
ATE419008T1 (de) Adjuvante zusammensetzung und anwendungsverfahren dafür
CY1109349T1 (el) Hsp60 απο arthrobacter
WO2002055100A3 (en) Method and composition for inhibition of tumor growth and enhancing an immune response
NZ542328A (en) Use of immune stimulating complex (ISCOM) particles as an adjuvant for an antigenic composition that comprises live micro organisms
WO2002024730A3 (en) Transduction of dendritic cells using adenoviral vectors
EP2147682A3 (en) Vaccination with immuno-isolated cells producing an immunomodulator
EP1591520A3 (en) Microorganism producing L-threonine having inactivated tyR gene, method of producing the same and method of producing L-threonine using the microorganism
WO2002032455A3 (en) Vaccine
AU2002246867A1 (en) The use of immature dendritic cells to silence antigen specific cd8+t cell function
AU2003229435A1 (en) Pathogen vaccines and methods for using the same
EP1401493B8 (en) Subunit vaccines and processes for the production thereof
AU2002360791A8 (en) Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells
EP1605039A4 (en) DENDRITIC CELL HAVING ALPHA-GLYCOSYLCERAMIDE DERIVATIVES AND ANTIGEN AND USEFUL IN REMOVAL OF IMMUNE RESPONSE
WO2005005614A3 (en) Combined b-cell and t-cell epitopes on vlp for improved vaccines
WO2000073415A3 (en) A method for the transfer of antigens to dendritic cells
WO2004022724A3 (en) Adoptive transfer and uses thereof
WO2003100027A3 (en) Mutant fibronectin and tumor metastasis
UA67549A (en) Method for grinding polymer-containing materials